The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
02/24/2023 | Angus Stewart | 8 min read
Industry experience needn’t always come post-academia – other options are available, as we learned in our chat with this Northern Irish PhD candidate
02/22/2023 | Stephanie Sutton
A video interview tackling the post-pandemic challenges of the events industry
02/20/2023
Download our eBook to find out how the industry is trying to be more sustainable.
02/13/2023 | James Wilson, Anshul Mangal | 5 min read
An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?
02/09/2023 | Stephanie Sutton | 2 min read
The first Humira biosimilar in the US is here, but market penetration could be a challenge.
02/01/2023 | Stephanie Sutton | 4 min read
Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.
01/31/2023 | Angus Stewart | 8 min read
Our priorities paint a picture of who we are, and that’s as true in RNAi medicine development as it is elsewhere in life
01/31/2023 | Angus Stewart | 12 min read
Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.
01/20/2023 | Angus Stewart | 2 min read
Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why
01/18/2023 | Stephanie Sutton | 3 min read
Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse